“This series is an opportunity for clinical researchers to advance their knowledge on the what, how, and when of successfully incorporating PROs to achieve development objectives and meet regulatory and commercialization expectations,” said Dr. Jean Paty.
Pittsburgh, PA (PRWEB) June 13, 2011
invivodata inc.®, the industry leader in patient reported outcomes (PRO) solutions and services for global clinical research, along with its scientific and regulatory consulting division, PRO Consulting®, today opened registration for its PROficiency™ Regional Conference Series. Occurring throughout Europe and the US, this series of 1-day educational events is designed to provide current, practical information on the effective use of PRO throughout all stages of clinical research.
The series, which is an extension of invivodata’s ongoing educational initiative, Proficiency™ 2011, will take place in the following locations:
- Tuesday, September 13 – London, England
- Thursday, September 15 – Amsterdam, The Netherlands
- Tuesday, September 20 – Boston, MA (US)
- Thursday, September 22 – Princeton, NJ (US)
- Tuesday, September 27 – San Francisco, CA (US)
- Thursday, September 29 – Research Triangle Park, NC (US)
- Thursday, October 13 – Basel, Switzerland
“This series is an opportunity for clinical researchers to advance their knowledge on the what, how, and when of successfully incorporating PROs to achieve development objectives and meet regulatory and commercialization expectations,” said Dr. Jean Paty, invivodata Co-founder and PRO Consulting Chief Scientist and Regulatory Advisor. “We’re excited to take this educational program on the road, and to have our esteemed colleagues share their wealth of knowledge on patient reported outcomes with a broad, international audience.”
The fall series features general sessions led by international biopharmaceutical professionals and industry experts, including:
- Dr. Karoly Kulich, PRO Expert, Novartis Pharmaceuticals; Basel, Switzerland
- Dr. David Reasner, Sr. VP Data Research, Sunovion Pharmaceuticals; Marlborough, MA
- Jan Breemans, eClinical Manager, Grünenthal GmbH; Aachen, Germany
- Dr. John Powers, Asst. Clinical Professor of Medicine, George Washington University School of Medicine; Washington, DC
- Ari Gnanasakthy, PRO Expert, Novartis Pharmaceuticals; East Hanover, NJ
- Dr. Mike Tansey, Managing Partner, CDDI; USA
invivodata is offering a discount of over 30% off registration fees for attendees who register before July 31, 2011. For additional information and to register for the series, visit http://www.invivodata.com/proficiency-2011-regional-conference-series/.
invivodata is the only fully-integrated PRO Solutions Organization delivering regulatory-proven strategic consulting and practical ePRO solutions to biopharmaceutical companies who depend upon patient-centered research. From crafting PRO measurement strategy to collecting PRO data electronically, invivodata helps its customers strategically use patient reported data to support labeling claims, enhance market access, and meet other clinical program objectives. Through partnerships with leading CROs and eClinical technology providers, invivodata seamlessly integrates into the clinical trial ecosystem, helping to minimize operational risk and maximize efficiencies. invivodata’s solutions have been used in over 350 clinical programs and are built upon the industry-leading ePRO system in delivering primary efficacy data for global drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, PA., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, CA., USA. For more information, visit http://www.invivodata.com.
About PRO Consulting
PRO Consulting, a division of invivodata, inc., provides consulting services to help clinical research teams effectively develop, execute, and document patient reported outcome (PRO) strategies to support their clinical research objectives. The PRO Consulting team has worked on over 150 clinical studies in 50+ indications and has more than 265 years of cumulative experience in psychometrics, PRO study design, and migrating and validating electronic solutions to collect PRO data, and has extensive experience working with the FDA and other regulatory bodies. For more information please visit http://www.patientreported.com.